Effect of octreotide on human sphincter of oddi motility following liver transplantation

被引:15
作者
Weber, FH
Sears, RJ
Kendall, B
Pruett, TL
Shaffer, HA
Yeaton, P
机构
[1] UNIV VIRGINIA, HLTH SCI CTR, DIV GASTROENTEROL & HEPATOL, DEPT MED, CHARLOTTESVILLE, VA 22906 USA
[2] UNIV VIRGINIA, HLTH SCI CTR, DEPT RADIOL, CHARLOTTESVILLE, VA 22906 USA
[3] UNIV VIRGINIA, HLTH SCI CTR, DEPT SURG, CHARLOTTESVILLE, VA 22906 USA
关键词
biliary tract; gastrointestinal motility; octreotide; sphincter of Oddi;
D O I
10.1023/A:1018885519918
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The effect of octreotide on sphincter of Oddi motility was investigated in six liver transplant patients, employing percutaneous (through the T-tube tract) manometry. Continuous and simultaneous sphincter of Oddi and duodenal motor activities were recorded before and for 60 min after the administration of octreotide (100 mu g subcutaneously) and after the injection of cholecystokinin (0.02 mu g/kg intravenously). With octreotide, contraction frequency and basal pressure significantly increased (P < 0.05). This effect lasted more than 60 min? long after octreotide-induced duodenal migrating motor complex phase III activity had ceased. Sphincter of Oddi contraction amplitude and duration were unaffected by octreotide. Subsequent cholecystokinin administration transiently reduced sphincter of Oddi basal pressure and contraction frequency. We conclude that octreotide significantly increases sphincter of Oddi basal pressure and contraction frequency. This effect is distinct from octreotide induction of migrating motor complex phase III activity, persists for a prolonged period, and is inhibited by cholecystokinin.
引用
收藏
页码:1168 / 1175
页数:8
相关论文
共 37 条
  • [11] SOMATOSTATIN AND SOMATOSTATIN ANALOG (SMS-201-995) IN TREATMENT OF HORMONE-SECRETING TUMORS OF THE PITUITARY AND GASTROINTESTINAL-TRACT AND NON-NEOPLASTIC DISEASES OF THE GUT
    GORDEN, P
    COMI, RJ
    MATON, PN
    GO, VLW
    [J]. ANNALS OF INTERNAL MEDICINE, 1989, 110 (01) : 35 - 50
  • [12] GROSMAN I, 1990, AM J GASTROENTEROL, V85, P1061
  • [13] EFFECT OF SOMATOSTATIN-14 ON PURE HUMAN PANCREATIC-SECRETION
    GULLO, L
    PRIORI, P
    SCARPIGNATO, C
    BALDONI, F
    MATTIOLI, G
    BARBARA, L
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1987, 32 (10) : 1065 - 1070
  • [14] THERAPEUTIC EFFICACY OF THE SOMATOSTATIN ANALOG SMS-201-995 (OCTREOTIDE) IN ACROMEGALY - EFFECTS OF DOSE AND FREQUENCY AND LONG-TERM SAFETY
    HO, KY
    WEISSBERGER, AJ
    MARBACH, P
    LAZARUS, L
    [J]. ANNALS OF INTERNAL MEDICINE, 1990, 112 (03) : 173 - 181
  • [15] DYSMOTILITY DISTURBANCES OF THE BILIARY-TRACT - CLASSIFICATION, DIAGNOSIS, AND TREATMENT
    HOGAN, WJ
    GEENEN, JE
    DODDS, WJ
    [J]. SEMINARS IN LIVER DISEASE, 1987, 7 (04) : 302 - 310
  • [16] KING CE, 1988, GASTROENTEROLOGY, V94, pA227
  • [17] Kohler E, 1986, Pancreas, V1, P154, DOI 10.1097/00006676-198603000-00008
  • [18] SOMATOSTATINOMA SYNDROME - BIOCHEMICAL, MORPHOLOGIC AND CLINICAL-FEATURES
    KREJS, GJ
    ORCI, L
    CONLON, JM
    RAVAZZOLA, M
    DAVIS, GR
    RASKIN, P
    COLLINS, SM
    MCCARTHY, DM
    BAETENS, D
    RUBENSTEIN, A
    ALDOR, TAM
    UNGER, RH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (06) : 285 - 292
  • [19] EFFECT OF THE SOMATOSTATIN ANALOG SANDOSTATIN (SMS 201-995) ON GASTROINTESTINAL, PANCREATIC AND BILIARY FUNCTION AND HORMONE-RELEASE IN NORMAL MEN
    LEMBCKE, B
    CREUTZFELDT, W
    SCHLESER, S
    EBERT, R
    SHAW, C
    KOOP, I
    [J]. DIGESTION, 1987, 36 (02) : 108 - 124
  • [20] BIOCHEMISTRY AND PHYSIOLOGY OF GASTROINTESTINAL SOMATOSTATIN
    LUCEY, MR
    YAMADA, T
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1989, 34 (03) : S5 - S13